FG-3246 (also known as FOR46) is a potential first-in-class fully human antibody-drug conjugate (ADC), exclusively in-licensed from Fortis Therapeutics, and is being developed by FibroGen for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback